Capecitabine monotherapy in advanced breast cancer resistant to anthracycline and taxane: A meta-analysis

Conclusions: Our meta-analysis demonstrated that capecitabine monotherapy could be the first choice for ABC pretreated with anthracycline and taxane due to its efficacy and low toxicity.

Source: Journal of Cancer Research and Therapeutics - December 11, 2018 Category: Cancer & Oncology Authors: Zhansheng Jiang Yanfang Yang Ling Li Zhensong Yue Lan Lan Zhanyu Pan Source Type: research